SEC Tracker
Get the app

Avalo Therapeutics AVTX

Avalo Therapeutics announces stock sale agreement

Securities offering

Form
424B5
Filed
Importance
Routine
  1. Up to $200,000,000 in common stock sales
  2. Sales agreement with Jefferies LLC
  3. Common stock listed on Nasdaq with price $7.07

Written from the 424B5 on EDGAR. AI can make mistakes. Check the filing.

Open in the appGet the appView on EDGAR

Get an email when Avalo Therapeutics files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 2834 and related industry codes: the same peer list as the financial tables.

  1. Cue Biopharma CUE public float $52M, Jun 30, 2025
  2. Fitlife Brands FTLF public float $51M, Jun 30, 2025
  3. Immucell ICCC public float $51M, Jun 30, 2025
  4. iBio IBIO public float $58M, Dec 31, 2025
  5. Sutro Biopharma STRO public float $60M, Jun 30, 2025

Data on this page was fetched . The filing on SEC.gov is the record.